Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-03-01 @ 11:27 AM
Study NCT ID:
NCT05293912
Status:
TERMINATED
Last Update Posted:
2025-03-18
First Post:
2022-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.
Sponsor:
Hangzhou Sumgen Biotech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-03
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-01
First Submit QC Date:
None
Study First Post Date:
2022-03-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-14
Last Update Post Date:
2025-03-18
Last Update Post Date Type:
ACTUAL